scPharmaceuticals Inc. (SCPH)
NASDAQ: SCPH · Real-Time Price · USD
5.21
+0.13 (2.56%)
At close: Aug 1, 2025, 4:00 PM
5.17
-0.04 (-0.77%)
After-hours: Aug 1, 2025, 4:24 PM EDT
scPharmaceuticals Revenue
scPharmaceuticals had revenue of $11.75M in the quarter ending March 31, 2025, with 92.59% growth. This brings the company's revenue in the last twelve months to $41.98M, up 138.10% year-over-year. In the year 2024, scPharmaceuticals had annual revenue of $36.33M with 167.28% growth.
Revenue (ttm)
$41.98M
Revenue Growth
+138.10%
P/S Ratio
5.94
Revenue / Employee
$255,988
Employees
164
Market Cap
272.93M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 36.33M | 22.74M | 167.28% |
Dec 31, 2023 | 13.59M | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | - | - | - |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 57.37B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
SCPH News
- 1 day ago - scPharmaceuticals to Announce Second Quarter 2025 Financial Results After the Market Close on August 7, 2025 - GlobeNewsWire
- 2 months ago - scPharmaceuticals: Furoscix Sales To Accelerate Throughout 2025 - Seeking Alpha
- 2 months ago - scPharmaceuticals Inc. (SCPH) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - scPharmaceuticals Inc. Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - scPharmaceuticals to Announce First Quarter 2025 Financial Results After the Market Close on May 14, 2025 - GlobeNewsWire
- 3 months ago - scPharmaceuticals Announces Participation in Three Upcoming Investor Conferences - GlobeNewsWire
- 4 months ago - scPharmaceuticals Inc. (SCPH) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewsWire